Catalyst Biosciences, Inc.
(NASDAQ : CBIO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.00%88.461.3%$921.65m
AMGNAmgen Inc.
0.03%191.291.2%$567.39m
ONCESpark Therapeutics, Inc.
0.18%113.7911.2%$468.71m
GILDGilead Sciences, Inc.
-0.70%65.170.9%$447.70m
BIIBBiogen Inc.
-1.28%325.641.3%$355.85m
BPTHBio-Path Holdings, Inc.
-5.38%27.82190.1%$311.93m
REGNRegeneron Pharmaceuticals, Inc.
-1.28%409.182.6%$285.34m
ILMNIllumina, Inc.
-1.44%305.393.5%$272.21m
VRTXVertex Pharmaceuticals Incorporated
-0.20%187.711.9%$243.74m
SRPTSarepta Therapeutics, Inc.
0.06%128.4415.4%$216.62m
EXASExact Sciences Corporation
-3.87%91.5225.3%$192.07m
ALXNAlexion Pharmaceuticals, Inc.
-0.96%134.782.0%$180.79m
AAgilent Technologies, Inc.
-0.58%80.631.6%$154.79m
BMRNBioMarin Pharmaceutical Inc.
-0.58%93.994.3%$100.08m
IONSIonis Pharmaceuticals, Inc.
0.10%78.628.3%$100.04m

Company Profile

Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel medicines to address serious medical conditions. Its pipeline includes hemostasis such as Factor VIIa marzeptacog alfa, Factor IX dalcinonacog alfa, and Factor Xa; and anti-complement. The company was founded on August 20, 2015 and is headquartered in South San Francisco, CA.